Systematic Comparison of Methods for Determining the in vivo Biodistribution of Porous Nanostructured Injectable Inorganic Particles

With a wide variety of biodistribution measurement techniques reported in the literature, it is important to perform side-by-side comparisons of results obtained with different methods on the same particle platform, to determine differences across methods, highlight advantages and disadvantages, and inform methods selection according to specific applications. Inorganic nanostructured particles (INPs) have gained a central role in the development of injectable delivery vectors thanks to their controllable design, biocompatibility, and favorable degradation kinetic. Thus, accurate determination of in vivo biodistribution of INPs is a key aspect of developing and optimizing this class of delivery vectors. In this study, a systematic comparison of spectroscopy (inductively coupled plasma optical emission spectroscopy), fluorescence (in vivo imaging system, confocal microscopy, and plate reader), and radiolabeling (gamma counter)-based techniques is performed to assess the accuracy and sensitivity of biodistribution measurements in mice. Each method is evaluated on porous silicon particles, an established and versatile injectable delivery platform. Biodistribution is evaluated in all major organs and compared in terms of absolute results (%ID/g and %ID/organ when possible) and sensitivity (σ%). Finally, we discuss how these results can be extended to inform method selection for other platforms and specific applications, with an outlook to potential benefit for pre-clinical and clinical studies. Overall, this study presents a new practical guide for selection of in vivo biodistribution methods that yield quantitative results.

[1]  C. Brinker,et al.  Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics , 2018, Nature Communications.

[2]  M. Ferrari,et al.  Alternating block copolymer-based nanoparticles as tools to modulate the loading of multiple chemotherapeutics and imaging probes. , 2018, Acta biomaterialia.

[3]  M. Zyuzin,et al.  Porous Inorganic Carriers Based on Silica, Calcium Carbonate and Calcium Phosphate for Controlled/Modulated Drug Delivery: Fresh Outlook and Future Perspectives , 2018, Pharmaceutics.

[4]  Doug W. Smith,et al.  Advantages and Limitations of Current Techniques for Analyzing the Biodistribution of Nanoparticles , 2018, Front. Pharmacol..

[5]  S. Nizzero,et al.  Ultra-small dye-doped silica nanoparticles via modified sol-gel technique , 2018, Journal of Nanoparticle Research.

[6]  Mauro Ferrari,et al.  Transport Barriers and Oncophysics in Cancer Treatment. , 2018, Trends in cancer.

[7]  Doug W. Smith,et al.  Advantages and Limitations of Current Imaging Techniques for Characterizing Liposome Morphology , 2018, Front. Pharmacol..

[8]  M. Ferrari,et al.  A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery , 2017, Scientific Reports.

[9]  Ian D. McGilvray,et al.  Mechanism of hard nanomaterial clearance by the liver , 2016, Nature materials.

[10]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[11]  Mauro Ferrari,et al.  An injectable nanoparticle generator enhances delivery of cancer therapeutics , 2016, Nature Biotechnology.

[12]  Anne L. van de Ven,et al.  Cell source determines the immunological impact of biomimetic nanoparticles. , 2016, Biomaterials.

[13]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[14]  Ester Segal,et al.  Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues , 2015, Nature Communications.

[15]  M. Ferrari,et al.  Porous silicon microparticles for delivery of siRNA therapeutics. , 2015, Journal of visualized experiments : JoVE.

[16]  M. Ferrari,et al.  Degradation and biocompatibility of multistage nanovectors in physiological systems. , 2014, Journal of biomedical materials research. Part A.

[17]  M. Ferrari,et al.  Bone marrow endothelium-targeted therapeutics for metastatic breast cancer. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[18]  P Olivero,et al.  Beating the Abbe diffraction limit in confocal microscopy via nonclassical photon statistics. , 2014, Physical review letters.

[19]  M. Ferrari,et al.  High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. , 2013, ACS nano.

[20]  Mauro Ferrari,et al.  Porous silicon advances in drug delivery and immunotherapy. , 2013, Current opinion in pharmacology.

[21]  M. Ferrari,et al.  Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice , 2012, Advanced functional materials.

[22]  Mauro Ferrari,et al.  Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Mauro Ferrari,et al.  Tailored porous silicon microparticles: fabrication and properties. , 2010, Chemphyschem : a European journal of chemical physics and physical chemistry.

[24]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[25]  J. Capeau,et al.  Haemoglobin interferes with the ex vivo luciferase luminescence assay: consequence for detection of luciferase reporter gene expression in vivo , 2000, Gene Therapy.